Effects of Hylocereus polyrhizus Peel Extract on Cardiac Biochemical and Histopathological Alterations in High-fat Diet/Streptozotocin-induced Diabetic Rats

Diabetes mellitus is associated with myocardial biochemical and structural alterations involving oxidative stress and inflammation. This study evaluated red dragon fruit peel extract (DFE) on cardiac biochemical markers and myocardial histopathology in a high-fat diet/streptozotocin (HFD/STZ) rat model of diabetes. Thirty male Wistar rats were randomised into five groups ( n = 6): non-diabetic control, diabetic control and three DFE groups (250, 500 and 1,000 mg/kg BW) administered orally once daily. The experimental period spanned 56 days from STZ induction to termination, with 51 days of treatment. Serum IL-1β, NT-proBNP and ROS, myocardial TGF-β1 immunoreactivity, and histopathological injury, inflammation and cardiomyocyte hypertrophy were assessed. DFE significantly reduced fasting blood glucose relative to the diabetic control at all three doses ( p < 0.001), with no significant differences among doses. Serum IL-1β and NT-proBNP immunoassay values were also significantly lower at all three doses ( p < 0.001), and the signal from a commercial ROS immunoassay was lower at all doses ( p < 0.05); the calibration of these three assays could not be verified and the molecular target of the ROS assay is not disclosed by its manufacturer, so their values are reported as relative between-group comparisons rather than as quantified concentrations. Histopathological injury was significantly reduced by all DFE doses, and inflammation and cardiomyocyte hypertrophy by the two higher doses (500 and 1,000 mg/kg), after correction for multiple comparisons. Myocardial TGF-β1 immunoreactivity was significantly lower at 1,000 mg/kg than in the diabetic control (corrected p = 0.022), although TGF-β1 did not differ significantly between the diabetic and non-diabetic controls (corrected p = 0.108). DFE was associated with improved glycaemic control and with reduced myocardial histopathological alteration in this model; because DFE also lowered blood glucose, its cardiac effects cannot be separated from improved glycaemic control.

Authors

Institutions

Publication Details

Journal
Journal of Applied Pharmaceutical Science
Published
2026-11-18
DOI
https://doi.org/10.1177/22313354261496710
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effects of Hylocereus polyrhizus Peel Extract on Cardiac Biochemical and Histopathological Alterations in High-fat Diet/Streptozotocin-induced Diabetic Rats

Gusbakti Rusip, Ade Indra Mukti, Taufik Delfian, Lia Restimulia et al.
1 links
Journal of Applied Pharmaceutical Science
Natural Antidiabetic Agents Studies
article

Effects of Hylocereus polyrhizus Peel Extract on Cardiac Biochemical and Histopathological Alterations in High-fat Diet/Streptozotocin-induced Diabetic Rats

Gusbakti Rusip, Ade Indra Mukti, Taufik Delfian, Lia Restimulia, Anisa Taqwa Lubis, Cashtry Meher, Nicholas Romin
article en

Abstract

Diabetes mellitus is associated with myocardial biochemical and structural alterations involving oxidative stress and inflammation. This study evaluated red dragon fruit peel extract (DFE) on cardiac biochemical markers and myocardial histopathology in a high-fat diet/streptozotocin (HFD/STZ) rat model of diabetes. Thirty male Wistar rats were randomised into five groups ( n = 6): non-diabetic control, diabetic control and three DFE groups (250, 500 and 1,000 mg/kg BW) administered orally once daily. The experimental period spanned 56 days from STZ induction to termination, with 51 days of treatment. Serum IL-1β, NT-proBNP and ROS, myocardial TGF-β1 immunoreactivity, and histopathological injury, inflammation and cardiomyocyte hypertrophy were assessed. DFE significantly reduced fasting blood glucose relative to the diabetic control at all three doses ( p < 0.001), with no significant differences among doses. Serum IL-1β and NT-proBNP immunoassay values were also significantly lower at all three doses ( p < 0.001), and the signal from a commercial ROS immunoassay was lower at all doses ( p < 0.05); the calibration of these three assays could not be verified and the molecular target of the ROS assay is not disclosed by its manufacturer, so their values are reported as relative between-group comparisons rather than as quantified concentrations. Histopathological injury was significantly reduced by all DFE doses, and inflammation and cardiomyocyte hypertrophy by the two higher doses (500 and 1,000 mg/kg), after correction for multiple comparisons. Myocardial TGF-β1 immunoreactivity was significantly lower at 1,000 mg/kg than in the diabetic control (corrected p = 0.022), although TGF-β1 did not differ significantly between the diabetic and non-diabetic controls (corrected p = 0.108). DFE was associated with improved glycaemic control and with reduced myocardial histopathological alteration in this model; because DFE also lowered blood glucose, its cardiac effects cannot be separated from improved glycaemic control.

Journal of Applied Pharmaceutical Science
Universitas Prima Indonesia (ID)
Good health and well-being
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon